AA

Ankur Agarwal

Director Director DIN 05146230
DIN 05146230 First appointment Dec 2011 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Ankur Agarwal

Data last updated:

Ankur Agarwal was a Director at Xyno Exim Private Limited (2018–2020) and Director at Vatsalaya Residency Private Limited (from 2011). The companies operate in Pharma.

DIN 05146230
Primary Designation Director
Industry Pharma
First Appointment 15 Dec 2011
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Xyno Exim Private Limited U74999RJ2018PTC061354
Director24 May 20182018Strike Off
Vatsalaya Residency Private Limited U70101RJ2011PTC037337
Director15 Dec 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vatsalaya Residency Private Limited
Xyno Exim Private Limited
Premium access

Shareholding and investment profile for Ankur Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankur Agarwal

Ankur Agarwal was first appointed on 15 Dec 2011 as Director at Vatsalaya Residency Private Limited. The most recent appointment on record is 24 May 2018 at Xyno Exim Private Limited.

Ankur Agarwal held 2 earlier board appointments: Xyno Exim Private Limited (Director, 24 May 2018 to 25 May 2020); Vatsalaya Residency Private Limited (Director, from 15 Dec 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available